NC TraCS Institute logo

UNC Health Care site of Adaptable study exceeds enrollment target

Enrollment of UNC Health Care System (UNCHCS) patients into the multi-site Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) study has reached 581 participants, exceeding the UNCHCS site's original enrollment target of 500 participants.

The ADAPTABLE study is a three-year pragmatic clinical trial comparing two different doses of daily aspirin to evaluate which dose is more effective at preventing heart attacks and strokes for patients with cardiovascular disease. The study is being conducted at sites across the United States, with a recruitment goal of 15,000 participants.

Darren DeWalt, MD, MPH

At UNCHCS, the ADAPTABLE study is led by Darren DeWalt, MD, MPH, Chief of the Division of General Medicine & Clinical Epidemiology at the University of North Carolina at Chapel Hill School of Medicine and the site PI.

"Recruitment is one of the most challenging aspects of many studies," said DeWalt. "Our ADAPTABLE team worked closely with TraCS to streamline recruitment processes through email and MyUNCChart. These methods enabled us to exceed our goal with modest resources."

Continue Reading

Know any news related to Translational & Clinical Research?
Share a Story

Media Contact:

Michelle Maclay, Communications Director